1. Home
  2. MBUU vs PRTA Comparison

MBUU vs PRTA Comparison

Compare MBUU & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Malibu Boats Inc.

MBUU

Malibu Boats Inc.

HOLD

Current Price

$28.79

Market Cap

560.3M

Sector

Industrials

ML Signal

HOLD

Logo Prothena Corporation plc

PRTA

Prothena Corporation plc

HOLD

Current Price

$9.32

Market Cap

495.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBUU
PRTA
Founded
1982
2012
Country
United States
Ireland
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
560.3M
495.8M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
MBUU
PRTA
Price
$28.79
$9.32
Analyst Decision
Buy
Buy
Analyst Count
9
9
Target Price
$33.88
$18.86
AVG Volume (30 Days)
215.8K
783.4K
Earning Date
01-29-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.98
N/A
Revenue
$830,714,000.00
$11,786,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$6.92
$819.08
P/E Ratio
$29.05
N/A
Revenue Growth
11.54
N/A
52 Week Low
$24.07
$4.32
52 Week High
$42.49
$16.67

Technical Indicators

Market Signals
Indicator
MBUU
PRTA
Relative Strength Index (RSI) 48.43 40.53
Support Level $28.85 $9.23
Resistance Level $29.51 $9.88
Average True Range (ATR) 0.84 0.46
MACD -0.05 -0.06
Stochastic Oscillator 0.22 16.78

Price Performance

Historical Comparison
MBUU
PRTA

About MBUU Malibu Boats Inc.

Malibu Boats is a designer and manufacturer of power boats in the United States. It is a market leader in performance sport boats, sold under its Malibu and Axis brands. It acquired Cobalt Boats, a producer of sterndrive boats, in 2017, and Pursuit Boats, which makes high end offshore and outboard motorboats in 2018. In 2021, it purchased Maverick Boat Group, a seller of flat fishing boats, with exposure to bay, dual console, and center console boats. Malibu has also expanded into boat trailers and accessories, and in 2020, began producing its own engines for its performance sport boats.

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

Share on Social Networks: